2 exciting mid cap ASX shares to buy and hold

Adore Beauty Group Limited (ASX:ABY) and this ASX mid cap share could be great long term options for investors. Here's why…

| More on:
Cutout icon of a lightbulb surrounded by 3 hands holding out gold coins

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are interested in investing in some promising mid cap shares, then you may want to take a look at the two listed below.

Both have a lot of potential and have been rated as buys recently. Here's what you need to know about these ASX shares:

Adore Beauty Group Limited (ASX: ABY)

The first mid cap share to look at is Adore Beauty. It is a growing online beauty retailer that has almost 600,000 active customers in an Australian beauty and personal market worth ~$11 billion a year.

Analysts at Morgan Stanley are big fans of the company and believe its shares are in the buy zone right now. Particularly given how far they have fallen from their IPO price of $6.75 late last year.

Another positive its outlook. Due to the growing popularity of its website and the ongoing shift to online shopping, Adore Beauty has been tipped for strong growth in the coming years.

Morgan Stanley has an overweight rating and $8.35 price target on the company's shares. This compares to the current Adore Beauty share price of $6.17.

ELMO Software Ltd (ASX: ELO)

Another mid cap ASX share to look at is ELMO. It is a cloud-based human resources and payroll software company.

ELMO's software gives businesses a unified platform to streamline processes such as employee administration, recruitment, and payroll. It has recently been bolstering its offering further with the acquisitions of Webexpenses for 13 million pounds and Breathe for $32 million.

The acquisition of these UK based businesses has gone down reasonably well with analysts at Morgan Stanley. The broker was also pleased to see that management has reiterated its organic growth guidance for FY 2021.

In light of this, Morgan Stanley has recently put an overweight rating and $9.70 price target on its shares. This compares to the latest ELMO share price of $7.00.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Elmo Software. The Motley Fool Australia owns shares of and has recommended Elmo Software. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Growth Shares

3 monster stocks to hold for the next 3 years

These 3 ASX shares operate in different industries and could be worth holding for long-term growth over the next 3…

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 ASX growth shares to snap up while they're still down

Brokers see plenty of upside for these mainstay sector picks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

Why these ASX growth stocks could be much bigger in 2030 than today

These stocks have long growth runways and strong business models.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »